Fidelity Disruptive Medicine ETF
Filed by Fidelity Covington Trust. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| TMOThermo Fisher Scientific Inc | 3.83% | $2M |
| DHRDanaher Corp | 3.73% | $1.9M |
| NTRANatera Inc | 3.30% | $1.7M |
| ARGXargenx SE | 3.20% | $1.7M |
| ILMNIllumina Inc | 2.82% | $1.5M |
| MRNAModerna Inc | 2.72% | $1.4M |
| ALNYAlnylam Pharmaceuticals Inc | 2.33% | $1.2M |
| COGTCogent Biosciences Inc | 2.31% | $1.2M |
| ISRGIntuitive Surgical Inc | 2.05% | $1.1M |
| INSMInsmed Inc | 1.84% | $947.2K |
| PCVXVaxcyte Inc | 1.83% | $945.8K |
| EWEdwards Lifesciences Corp | 1.76% | $907.5K |
| WSTWest Pharmaceutical Services Inc | 1.72% | $886.9K |
| VEEVVeeva Systems Inc | 1.66% | $857.1K |
| UNHUnitedHealth Group Inc | 1.59% | $817.8K |
| AMLXAmylyx Pharmaceuticals Inc | 1.54% | $794.9K |
| GHGuardant Health Inc | 1.53% | $791.1K |
| RGENRepligen Corp | 1.47% | $760.1K |
| TWSTTwist Bioscience Corp | 1.35% | $695K |
| BSXBoston Scientific Corp | 1.14% | $588.5K |
| AXSMAxsome Therapeutics Inc | 1.06% | $546.3K |
| VCYTVeracyte Inc | 1.01% | $519.2K |
| LLYEli Lilly and Co | 0.89% | $456.9K |
| RLAYRelay Therapeutics Inc | 0.86% | $441.1K |
| IRTCiRhythm Holdings, Inc | 0.80% | $412.8K |
| DXCMDexcom Inc | 0.71% | $364.2K |
| PRAXPraxis Precision Medicines Inc | 0.68% | $350.3K |
| BRKRBruker Corp | 0.61% | $313.3K |
| GPCRStructure Therapeutics Inc | 0.41% | $212.5K |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow Fidelity Disruptive Medicine ETF by email
Fidelity Disruptive Medicine ETF's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.